We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
-2.99%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$1.7B
AUM Growth
-$507M
Cap. Flow
-$382M
Cap. Flow %
-22.43%
Top 10 Hldgs %
66.15%
Holding
139
New
17
Increased
28
Reduced
53
Closed
24

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$25.8M
2
NICE icon
Nice
NICE
+$21M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$18.3M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$16.6M
5
SLB icon
SLB Ltd
SLB
+$13.6M

Top Sells

Rank Stock Value
1
CCJ icon
Cameco
CCJ
+$102M
2
ZTO icon
ZTO Express
ZTO
+$77M
3
PDD icon
Pinduoduo
PDD
+$68.4M
4
MCHP icon
Microchip Technology
MCHP
+$57.6M
5
TCOM icon
Trip.com Group
TCOM
+$51.3M

Sector Composition

Rank Sector Weight
1 Financials 19.1%
2 Technology 16.24%
3 Industrials 13.83%
4 Communication Services 13.45%
5 Energy 13.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRMD icon
51
TORM
TRMD
$3.02B
$2.93M 0.17%
152,439
+73,240
+92% +$1.79M
MRUS
52
DELISTED
Merus
MRUS
$2.91M 0.17%
69,085
– –
GOSS icon
53
Gossamer Bio
GOSS
$87M
$2.88M 0.17%
3,180,295
-344,613
-10% -$295K
MA icon
54
Mastercard
MA
$493B
$2.86M 0.17%
+5,425
New +$2.81M
QTRX icon
55
Quanterix
QTRX
$190M
$2.77M 0.16%
260,181
-17,455
-6% -$212K
ACIU icon
56
AC Immune
ACIU
$240M
$2.57M 0.15%
952,069
– –
BABA icon
57
Alibaba
BABA
$308B
$2.45M 0.14%
28,845
-177,873
-86% -$16.8M
RCUS icon
58
Arcus Biosciences
RCUS
$3.64B
$2.29M 0.13%
153,783
– –
IMTX icon
59
Immatics
IMTX
$1.32B
$2.22M 0.13%
311,722
+108,108
+53% +$929K
TXN icon
60
Texas Instruments
TXN
$261B
$2.06M 0.12%
10,993
-1,304
-11% -$261K
GPCR icon
61
Structure Therapeutics
GPCR
$3.78B
$2.03M 0.12%
74,900
+17,670
+31% +$627K
ESPR
62
DELISTED
Esperion Therapeutics
ESPR
$1.85M 0.11%
840,052
-252,810
-23% -$590K
SWTX
63
DELISTED
SpringWorks Therapeutics
SWTX
$1.69M 0.1%
+46,895
New +$1.64M
ARWR icon
64
Arrowhead Research
ARWR
$12.4B
$1.66M 0.1%
88,425
– –
CDNS icon
65
Cadence Design Systems
CDNS
$93.4B
$1.64M 0.1%
5,448
+1,635
+43% +$475K
SNPS icon
66
Synopsys
SNPS
$79.7B
$1.61M 0.09%
3,317
+944
+40% +$493K
PTC icon
67
PTC
PTC
$16B
$1.55M 0.09%
+8,455
New +$1.6M
MGTX icon
68
MeiraGTx Holdings
MGTX
$1.21B
$1.52M 0.09%
250,000
– –
ABSI icon
69
Absci
ABSI
$1.51B
$1.44M 0.08%
551,188
+93,785
+21% +$330K
AURA icon
70
Aura Biosciences
AURA
$826M
$1.33M 0.08%
162,358
– –
ADSK icon
71
Autodesk
ADSK
$52.6B
$1.28M 0.08%
4,336
+2,628
+154% +$776K
LRCX icon
72
Lam Research
LRCX
$390B
$1.23M 0.07%
17,086
-10,164
-37% -$771K
COGT icon
73
Cogent Biosciences
COGT
$7.24B
$1.23M 0.07%
157,851
– –
SKYE icon
74
Skye Bioscience
SKYE
$18.3M
$1.23M 0.07%
434,046
-51,153
-11% -$214K
AMAT icon
75
Applied Materials
AMAT
$428B
$1.23M 0.07%
7,536
-3,735
-33% -$677K
1 2
3
4 5

Similar funds

LCG
Lisanti Capital Growth New York $397M AUM 178.66% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Platinum Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, Platinum Investment Management held 139 positions worth $1.7B, down 23% from $2.21B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Platinum Investment Management withdrew a net $382M in Q4 2024, closing 24 positions and reducing 53 holdings. Its most notable exit was Microchip Technology, an estimated $57.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

Against the trend, Platinum Investment Management opened a new position in ProQR Therapeutics worth $4.08M.

  • Platinum Investment Management's largest Q4 2024 buy was ProQR Therapeutics: 1,538,247 shares worth $4.08M.
  • Platinum Investment Management added most to Broadcom in Q4 2024, an estimated $25.8M increase.
  • Platinum Investment Management's biggest Q4 2024 reduction was Cameco, cutting an estimated $102M.
  • Platinum Investment Management fully exited Microchip Technology in Q4 2024, selling an estimated $57.6M.
  • Platinum Investment Management's ten largest holdings make up 66% of its $1.7B portfolio in Q4 2024.
  • Platinum Investment Management opened 17 new positions and closed 24 in Q4 2024.
  • Platinum Investment Management's portfolio value fell 23% quarter-over-quarter to $1.7B.

Based on Platinum Investment Management's 13F filing for Q4 2024, filed 11 Feb 2025.